Literature DB >> 30471884

In the Line of Fire: Should Urologists Stop Prescribing Fluoroquinolones as Default?

Gernot Bonkat1, Florian Wagenlehner2.   

Abstract

Fluoroquinolone use might be associated with serious side effects. Urologists should always consider these potential risks associated with fluoroquinolones and participate in a shared-decision making process with each patient. It is critical to strictly follow guidelines when prescribing fluoroquinolones.
Copyright © 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30471884     DOI： 10.1016/j.eururo.2018.10.057

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  3 in total

1.  Dangerous fluoroquinolones: The urologist's dilemma.

Authors:  J Curtis Nickel; R Christopher Doiron
Journal:  Can Urol Assoc J       Date:  2020-04-01       Impact factor: 1.862

Review 2.  Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability.

Authors:  Oskar Estradé; Valvanera Vozmediano; Nerea Carral; Arantxa Isla; Margarita González; Rachel Poole; Elena Suarez
Journal:  Antibiotics (Basel)       Date:  2022-05-11

Review 3.  Adherence to European Association of Urology Guidelines and State of the Art of Glycosaminoglycan Therapy for the Management of Urinary Tract Infections: A Narrative Review and Expert Meeting Report.

Authors:  Gernot Bonkat; Tommaso Cai; Carlotta Galeone; Bela Koves; Franck Bruyere
Journal:  Eur Urol Open Sci       Date:  2022-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.